We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current CVSI market cap is 6.14M. The company's latest EPS is USD and P/E is N/A.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 48.24M | 53.7M | 24.43M | 20.05M | 16.21M |
| Operating Income | 10.25M | -17.24M | -22.59M | -18.45M | -6.85M |
| Net Income | 10M | -16.64M | -22.28M | -15.55M | -9.13M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 36.9M | 52.69M | 30.63M | 18.07M | 12.74M |
| Total Liabilities | 6.79M | 23.54M | 19.41M | 14.52M | 13.51M |
| Total Equity | 30.12M | 29.15M | 11.21M | 3.54M | -777k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 12.56M | -2.23M | -7.3M | -7.49M | -1.89M |
| Investing | -1.24M | -1.15M | -1.06M | -85k | N/A |
| Financing | -1.17M | 47k | 3.27M | 4.37M | 1.12M |
| Market Cap | 6.14M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 154.6M |
| Average Volume (1 week) | 133k |
| Average Volume (1 Month) | 277.96k |
| 52 Week Change | -11.68% |
| 52 Week High | 0.06 |
| 52 Week Low | 0.0275 |
| Spread (Intraday) | 0 (4.28%) |
| Company Name | CV Sciences Inc (QB) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cvsciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
